Summary
In order to ascertain the protective role of a potent calcium entry blocking agent in human acute renal failure, 10 patients were randomised to treatment with either intrarenal gallopamil plus intravenous furosemide (frusemide) 0.5 mg/kg/h for 24 hours, or furosemide alone. Gallopamil was infused into each kidney at the rate of 40 to 80 µg/min for 4 hours. During 7 days of post-treatment follow-up, the gallopamil treatment group exhibited a significantly higher urine output [257 ml/h vs 81 ml/h (p < 0.001) after 2 days, and 199 ml/h vs 120 ml/h (p < 0.005) after 7 days] and creatinine clearance [20 vs 4 ml/min (p < 0.005) after 2 days, and 38 vs 14 ml/min (p < 0.001) after 7 days] than the furosemide-only control group. Furthermore, gallopamil treatment accelerated the decline of serum creatinine after renal failure and reduced the requirement for dialysis.
Although patient numbers were small, these results indicate that the addition of intrarenal gallopamil to intravenous furosemide treatment enhances the recovery of renal function after acute renal failure.
Similar content being viewed by others
References
Adams PL, Adams PF, Bell PD, Navar LG. Impaired renal blood flow autoregulation in ischemic acute renal failure. Kidney International 18: 68–76, 1980
Agatstein EH, Farrer JH, Kaplan LM, Randazzo RF, Glassock RJ, et al. The effect of verapamil in reducing the severity of acute tubular necrosis in canine renal autotransplants. Transplantation 44: 355, 1987
Arnold PE, Van Putten VJ, Lumlergul D, Burke TJ, Schrier RW. Adenonine nucleotide metabolism and mitochondria Ca+2 transport following renal ischemia. American Journal of Physiology 250: F357–F363, 1986
Burke TJ, Arnold PE, Gordon JA, Bulger RE, Dobyan DC, et al. Protective effect of intrarenal calcium membrane blockers before and after renal ischemia. Functional, morphological and mitochondrial studies. Journal of Clinical Investigation 74: 1830–1841, 1984
Burnier M, Van Putten V, Wilson P, Burke T, Schrier RW. Beneficial effects of verapamil and nifedipine on Ca+2 influx and cell viability in anoxic renal cortical proximal tubules. Mineral and Electrolyte Metabolism 11: 390–391, 1985
Conger JD. Vascular abnormalities in the maintenance of acute renal failure. Circulatory Shock 11: 235–244, 1983
Conger JD, Robinette JB, Schrier RW. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. Journal of Clinical Investigation 82: 532–537, 1988
Fleckenstein A, Fleckenstein B, Spah F, Byon YK. Gallopamil (D 600) a calcium antagonist of high potency and specificity. Effect on the myocardium and pacemakers. Gallopamil: pharmacological and clinical profile of a calcium antagonist, pp. 1–33, Springer-Verlag, New York, 1984
Frei U, Margreiter R, Harms A, Bosmuller C, Neuman KH, et al. Preoperative graft reperfusion with calcium antagonist improves initial function. Preliminary results. Transplantation Proceedings 19: 3539–3541, 1987
Goldfarb D, Iaina A, Serban I, Gavendo S, Kapuler S, Eliahou HE. Beneficial effect of verapamil in ischemic acute renal failure in the rat. Proceedings of the Society for Experimental Biology and Medicine 172: 389–392, 1983
Humes HD, Weinberg JM. Cellular energetics in acute renal failure. In Brenner BM, Saunders JM (Eds) Acute renal failure, pp. 47–98, WB Saunders, Philadelphia, 1983
Humes HD. Role of calcium in pathogenesis of acute renal failure. American Journal of Physiology 250: F579–F589, 1986
Kelleher SP, Robinette JB, Conger JD. Sympathetic nervous system in the loss of autoregulation in acute renal failure. American Journal of Physiology 246: F379–F386, 1984
Loutzenhiser R, Epstein M. Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists. American Journal of Nephrology 7: 7, 1987
Lumlertgul D, Hutdgoon P, Sirivanichai C, Keoplung M. Beneficial effect of intrarenal verapamil in human acute renal failure. Renal Failure 11; 201–208, 1990
Malis CD, Cheung JY, Leaf A, Bonventre JV. Effect of verapamil in models of ischemic acute renal failure in rat. American Journal of Physiology 245: 735–742, 1983
Matthys E, Patton M, Kosgood R, Venkatachalam M, Stein J. Alterations in vascular function and morphology in ischemic ARF. Kidney International 19: 399–409, 1983
Schrier RW, Arnold PE, Van Putten VJ, Burke TJ. Cellular calcium in ischemic acute renal failure. Role of calcium entry blockers. Kidney International 32: 313–321, 1987
Schrier RW, Arnold PE, Van Putten VJ, Burke TJ. Pathophysiology of cell ischemia. In Schrier RW, Gottschalk CW (Eds) Diseases of the kidney, pp. 1379–1412, Little, Brown & Co., Boston, 1988
Schrier RW, Burke TJ. Calcium-channel blockers in experimental and human acute renal failure. Advances in Nephrology from the Necker Hospital 17: 287–300, 1980
Schrier RW, Hensen J. Cellular mechanisms of ischemic acute renal failure. Role of Ca+2 and calcium entry blockers. Klinische Wochenschrift 66: 800–807, 1988
Shapiro JI, Cheuny C, Itabarhi A, Chan L, Schrier RW. The effect of verapamil on renal function after warm and cold ischemia in the isolated perfused rat kidney. Transplantation 40: 596, 1985
Stein JH, Meyer D, Lifschitz L, Barner LD. Current concepts on the pathophysiology of acute renal failure. American Journal of Physiology 234: F171–F181, 1978
Van Benthuysen KM, McMurty IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vivo. Journal of Clinical Investigation 79: 265–274, 1987
Wagner K, Albrecht S, Neumayer H-H. Protective action of the calcium antagonist diltiazem on acute renal failure following renal transplantation. Deutsche Medizinische Wochenschrift 36: 1363–1367, 1986
Wagner K, Albrecht S, Neumayer H-H. Prevention of post transplant acute tubular necrosis by the calcium antagonist diltiazem. A prospective randomized study. American Journal of Nephrology 7: 287–297, 1987
Wagner K, Neumayer H-H. The influence of the calcium antagonist diltiazem on acute renal failure after kidney transplantation. Results of two prospective trials. Medizinische Klinik 82: 171–177, 1987a
Wagner K, Neumayer H-H. Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation; results of a 6-month follow-up. Transplantation Proceedings 19: 1353, 1987b
Weinberg KM, Hujt D, Humes HD. Effect of verapamil on in vitro ischemic injury to isolated rabbit proximal tubules. Kidney International 25: 239, 1984
Williams RH, Thomas CE, Navar LG, Evans AP. Hemodynamic and single nephron function during the maintenance phase of ischemic acute renal failure in the dog. Kidney International 19: 505–515, 1981
Wooley JL, Barker GR, Jacobsen WK, et al. Effect of the calcium entry blocker, verapamil on renal ischemia. Critical Care Medicine 16: 48, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lumlertgul, D., Wongmekiat, O., Sirivanichai, C. et al. Intrarenal Infusion of Gallopamil in Acute Renal Failure. Drugs 42 (Suppl 1), 44–50 (1991). https://doi.org/10.2165/00003495-199100421-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199100421-00009